The Board is therefore seeking approval at the General Meeting to issue new shares on a non-pre-emptive basis for up to 40 per cent. of the Company's Enlarged Issued Share Capital (following Completion). The Board will update Shareholders as appropriate regarding any future funding proposals. It remains of the opinion that the NASDAQ Listing will provide access to specialist healthcare investors in the US.
Wow! A lot to take in but up to 40% dilution probably by Q3. Probably will keep the price where it is now as it’s 50% undervalue. 2022 is going to be an epic year. So much detail and nothing really to get upset about
Be nice to see what’s in progress and what still needs to be done rather than the broad terms “licence” and “financing” is what I’m getting at. It’s not a trade secret
Due this week. Given the falling SP I would suspect national matters have been identified which will slow the process right down. Shame but good opportunity to top up
Wouldn’t be surprised Gary to see another RNS in the morning or very soon validating what you’ve just said. What with the price of the metal as well. Just surprised at the price of the raise. Would have thought 10% discount at most
RE: Mm's will no doubt play games first thing in the morning.17 Feb 2021 21:27
I don’t think they’ll be able to as the news will drop. Of course we will see significant fluctuations in the SP as people have their exit or slice planned if they missed the rise up to 5p a few months ago